PS

Pascal Soria

Person

Heard in 3 episodes across 2 shows since Nov 2025

The excerpt appears to identify Pascal Soria as a chief executive involved in developing Ashton’s oncology business, but publicly established biographical details are unclear.

Email alerts

Episodes

3
across 2 shows

First heard

Nov 2025

Guest appearances

2

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Nov 20251
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20261
Jul 20260
Aug 20261
Sep 20260
Oct 20260

Email alert

Email me when Pascal Soria comes up on a podcast

One email a week at most, with the new episodes that mention Pascal Soria. Free, no account needed, unsubscribe in one click.

What Pascal Soria has said on podcasts

8 statements

  1. on AstraZenecaPositiveJun 5, 2026· Mad Money w/ Jim Cramer

    AstraZeneca will be the largest British company with a U.S. share in the United States.

    “We are going to be the largest British company with a U.S. share in the United States.”

    Listen at 13:11

    Open the episode · Mad Money w/ Jim Cramer 6/5/26
  2. on AstraZeneca New York listingPositiveJun 5, 2026· Mad Money w/ Jim Cramer

    The New York listing enables U.S. shareholders to buy AstraZeneca shares directly.

    “U.S. shareholders who are not comfortable or not able to buy an EDR can buy our shares.”

    Listen at 13:32

    Open the episode · Mad Money w/ Jim Cramer 6/5/26
  3. on AstraZeneca Kendall Square research centerPositiveJun 5, 2026· Mad Money w/ Jim Cramer

    AstraZeneca’s Kendall Square site will employ 3,000 pipeline scientists.

    “where we will have 3,000 scientists working on our pipeline.”

    Listen at 14:29

    Open the episode · Mad Money w/ Jim Cramer 6/5/26
See all 8 statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

3 episodes featuring Pascal Soria, newest first